Journal Watch · Frontiers in Immunology · 2026
Neural regulatory networks: challenges and opportunities in the treatment of psoriasis.
We aim to identify potential therapeutic targets and propose innovative strategies to improve clinical outcomes of patients with psoriasis.
TL;DR
We aim to identify potential therapeutic targets and propose innovative strategies to improve clinical outcomes of patients with psoriasis.
Key findings
- We aim to identify potential therapeutic targets and propose innovative strategies to improve clinical outcomes of patients with psoriasis.
What they did
Despite the recognized importance of these interactions, a comprehensive understanding of the underlying mechanisms between different cell types and the nervous system in psoriasis is still lacking. This review systematically explores the intricate regulatory interactions between multiple cellular components and the nervous system in psoriasis.
Full abstract (original)
Background: Psoriasis is a chronic systemic inflammatory skin disease characterized by complex pathogenic mechanisms involving various cellular interactions. The nervous system significantly influences the development and exacerbation of psoriatic lesions, particularly in innervated regions.
What they did: Despite the recognized importance of these interactions, a comprehensive understanding of the underlying mechanisms between different cell types and the nervous system in psoriasis is still lacking. This review systematically explores the intricate regulatory interactions between multiple cellular components and the nervous system in psoriasis.
Results & conclusions: We aim to identify potential therapeutic targets and propose innovative strategies to improve clinical outcomes of patients with psoriasis.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1942535 · PubMed 42775056.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
We aim to identify potential therapeutic targets and propose innovative strategies to improve clinical outcomes of patients with psoriasis.
What type of study is this?
It is a review / perspective, published in Frontiers in Immunology in 2026. Despite the recognized importance of these interactions, a comprehensive understanding of the underlying mechanisms between different cell types and the nervous system in psoriasis is still lacking.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1942535. PubMed ID: 42775056. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/neural-regulatory-networks-challenges-and-opportunities-in-the-treatment-942535/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides